Article

CURE's Top 5 Stories: May 2018

Take a look at the top five CURE stories of May 2018 in this video.

Here are the top 5 CURE stories for May 2018.

5. Surveillance of Survivors Can Save Lives

Second cancers are common among patients with lung cancer. We explore the risk factors and how they can be avoided in this piece, featured in our CURE Special Issue on Lung Cancer.

4. My New Normal Isn’t Quite So New Anymore

In this piece, CURE contributor Bonnie Annis explains how redefining “normal” is a vital part of a cancer survivor's post diagnosis timeline.

3. How to Talk to Kids About Cancer

CURE sat down with a childhood development specialist and a colorectal cancer survivor who offered firsthand advice on how to discuss a cancer diagnosis with children of any age.

2. The Special Relationship with My Oncologist

After years of distrust, CURE contributor Jane Biehl recalls how finding the right oncologist was like striking gold.

1. Mental Health Awareness Following a Cancer Diagnosis

With Mental Health Awareness Month coming to a close, this blog explores how openly discussing post-diagnosis mental health changes can improve mind and body wellness.

And in related news, CURE Media Group hosted two events at the Oncology Nursing Society’s 43rd Annual Congress in Washington, D.C.

On May 17th, Christine Stone was selected as this year’s recipient of the Extraordinary Healer Award for Oncology Nursing, and the first-ever Bone Health Champions gala was held on May 18th. Both events honored oncology nurses who have committed themselves to educating patients, raising awareness and making advancements in their fields.

For recaps on these events, along with all of our top stories, visit curetoday.com.

Related Videos
Dr. Laura Dawson, a professor and chair of the department of Radiation Oncology at the University of Toronto, and a practicing radiation oncologist in the Radiation Medicine Program at Princess Margaret Cancer Center, University Health Network in Toronto.
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Michael Bogenschutz, director of the NYU Langone Center for Psychedelic Medicine in New York,
1 expert is featured in this series.
Dr. Richard “Rick" Winneker
Dr Sattva S. Neelapu discusses data from the ZUMA-5 trial investigating the CAR T-cell therapy Yescarta in relapsed/refractory follicular lymphoma
1 expert is featured in this series.
Image of man with grey hair.
Related Content